Category: All

0
by in ,

PTS Diagnostics Announces Full Program Availability for PreVantage

PTS Diagnostics Announces Full Program Availability for PreVantage™

Subscription-Based Solutions Assist Healthcare Industry With Maximizing Reimbursement

INDIANAPOLIS – PTS Diagnostics, a U.S.-based manufacturer of point-of-care testing devices, announced today the full availability of the PreVantage population health program which includes product solutions and strategic partnerships. 

“We’re excited to evolve from a product-based organization into a turnkey solutions provider,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “The PreVantage suite of solutions will help PTS Diagnostics deliver unprecedented value in regards to assisting providers with maximizing healthcare reimbursement in a value-based model while improving both patient and provider satisfaction, and ultimately achieving measurable improvements in overall population health.”

This new brand is the culmination of extensive evidence-based research into the world of value-based incentivization and was developed to address the complex needs of multiple markets served by PTS Diagnostics.

“PTS Diagnostics is uniquely positioned to deliver this program as our product solutions generate the data required to help systems achieve the mandates of the Quadruple Aim, while helping providers maximize reimbursement under MIPS Advanced Alternative Payment Models,” said Steve Riendeau, Chief Commercial Officer of PTS Diagnostics. “By combining our products with leading software solutions under the PreVantage umbrella, we are also helping providers accelerate initiatives such as remote patient monitoring and chronic disease management program implementation.” 

PreVantage is composed of the following elements:

PreVantage™ Product Solutions are customized into two separate medical device convenience kits.

The A1CNow®+ product solution contains the 10-count A1CNow+ professional system with lancets, a removable pouch for ancillary components, and a robust outer case for greater mobility, protection, and storage.
The CardioChek® Plus product solution contains a professional CardioChek Plus analyzer, PTS Panels® Lipid + eGLU Smart Bundle 2-pack, lancets, PTS Collect™ 40 μL capillary tubes, PTS Panels Multi-Chemistry Controls, a removable pouch for ancillary components, and a robust outer case for greater mobility, protection, and storage.

These solutions come with an extended service agreement and warranty, as well as a lifetime guarantee on the outer case itself. PreVantage Product Solutions have the potential for expansion and customization as we explore new partnerships within the healthcare industry which support the PreVantage mission.

PreVantage ConnectedCare™, powered by Rimidi, is a population health chronic disease management solution, created by medical professionals, for medical professionals and patients. It unlocks the meaning in patient data, enabling personalized, focused, point-of-care solutions that can help improve outcomes, which is critical to provider reimbursement maximization. It works seamlessly into the physician or care team’s workflow and integrates directly with providers’ Electronic Health Records (EHRs), leveraging emerging industry standards like SMART on FHIR.

PreVantage ConnectedQC™, powered by eTrueNorth, is a point-of-care focused quality control management solution which assists users of PTS Diagnostics product solutions in managing their QC requirements in a manner consistent with current regulatory standards. PreVantage customers are also granted preferred access to eTrueNorth’s eQC suite of policy and procedure and national and state regulatory requirement management programs.

PTS Connect® ScreenPro, powered by StatBridge, assists healthcare systems with managing population-based and employer health screening events while connecting PTS Diagnostics’ systems to data capture solutions.

PTS Connect® ProLink, powered by mHealthAlert, wirelessly receives and securely stores biometric data from various diagnostics devices and delivers a personalized wellness report.

PreVantage will continue to expand nationally as healthcare shifts from a fee-for-service model to value-based incentivization. The brand will also mature globally as PTS Diagnostics assists with meeting unique healthcare needs abroad.

Interested parties are encouraged to visit ptsdiagnostics.com/prevantage, reach out to PTS Diagnostics via phone at 877-870-5610, or email at customerservice@ptsdiagnostics.com for more information.

About PTS Diagnostics Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 130 countries around the globe. For more information, visit ptsdiagnostics.com.

About PreVantage
PreVantage™ is a network of products, strategies, and partnerships aimed at helping healthcare organizations meet rapidly changing industry and consumer demands. By connecting innovations in technology, healthcare delivery, and payment models, PreVantage helps healthcare providers improve efficiency, lower costs, and increase reimbursements while delivering better health outcomes. More information is available at ptsdiagnostics.com/PreVantage.

Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610 – rsimpson@ptsdiagnostics.com

0
by in

PTS Diagnostics’ Global Headquarters Opening May 20 in Whitestown, Indiana

PTS Diagnostics’ Global Headquarters Opening May 20 in Whitestown, Indiana

State-of-the-art facility to serve as global manufacturing hub

INDIANAPOLIS (May 15, 2019) – PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that their new global headquarters is officially opening to all Indianapolis-area employees on Monday, May 20.

Located at 4600 Anson Boulevard, the 135,000 square foot facility will feature expanded manufacturing and office space, as well as amenities such as a walking trail, fitness center, zen garden, rec room, and more. The facility has recently led to material hiring in key departments such as research and development, operations, and manufacturing; a trend that PTS Diagnostics expects to continue for the foreseeable future.

The grand opening comes nearly a year to the day after a private groundbreaking ceremony was held with executives, architects, builders, and representatives from PTS Diagnostics’ parent company, Sinocare, Inc.

“Our growth rate has been significantly above the industry average for the past several years. This facility greatly expands our capacity, while ensuring that Indiana will remain our long-term home,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “Ultimately, it’s our vision to be recognized as the leading global customer-driven partner for providing innovative point-of-care solutions for preventative healthcare and disease management. This headquarters provides us with the resources to make this goal a reality.”

PTS Diagnostics employs more than 240 full-time employees domestically and internationally, with the majority of those employees residing at our new flagship location in Whitestown. PTS Diagnostics also has a Sunnyvale, California location which was acquired in 2013. 

The company is currently hiring in the fields of engineering, regulatory and compliance, sales, manufacturing and production, research and development, and marketing. Interested applicants are encouraged to monitor the PTS Diagnostics career center at ptsdiagnostics.com/career-center.

“We are pleased that PTS Diagnostics has chosen to bring their global headquarters to Whitestown,” said Molly Whitehead, Executive Director of the Boone County Economic Development Corporation. “We are confident that a thriving company like PTS Diagnostics will find Boone County to be a good fit for their operations.”

A ribbon-cutting celebration is scheduled for Saturday, June 22, employees, Whitestown business leaders, and members of the media are welcome to attend. More information will be available at a later date.

The old facility, located at 7736 Zionsville, Road, will remain open for disaster recovery and manufacturing needs. 

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.

Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610
rsimpson@ptsdiagnostics.com

0
by in

Q&A: Point-of-Care Solutions and the Changing Healthcare Environment

At PTS Diagnostics, people are essential to our organizational success. We caught up with Bridget Melland, Director of Corporate Accounts, to learn more about the impact that our solutions make on those with chronic conditions.

Here’s what she had to say:

Q: Describe your role and the impact that you hope to leave on population health.

A: I work with large corporate and retail accounts that utilize our point-of-care product lines. Together we introduce these chronic disease management solutions to end users with the goal of improving lives.

In order to develop chronic disease management programs at the corporate level, I first must ensure that I fully understand each client’s goals, objectives, and barriers. Active listening enables me to align the resources and tools that will help them reach their goals.

Successful programs have the potential to reach and improve the lives of individuals who may have been unreachable under the standard physician-centric healthcare model.

Q: What trends in the healthcare industry have you noticed over the past several years and how is PTS Diagnostics suited to take advantage of these trends?

A: Healthcare consumers are looking for care that is convenient and meets them where they are, e.g. pharmacies, dental offices, grocery stores, etc. More and more, wearables and apps are driving healthcare consumer engagement. I anticipate that this trend of digital reliance will only increase as younger generations become more comfortable with emergent technology.

Another prominent change that has occurred is in regard to healthcare reimbursement laws. Healthcare systems are now being rewarded, or penalized, based upon their ability to keep patients healthy – a reversal from the standard fee-for-service model. 

PTS Diagnostics is addressing both of these trends head-on with our new PreVantageTM suite of solutions which are intended to assist with optimizing reimbursement. PreVantage enables me to be a single point of contact that can offer a full portfolio of solutions, helping my clients to “bring it all together.”

Q: What does success look like to you and how do you achieve it?

A: To me, success comes through enabling consumers to access actionable results and engaged healthcare professionals in nontraditional settings.

Healthcare consumer testimonials that highlight how point-of-care technology and chronic disease management tools can improve the lives of those impacted by diabetes and associated comorbidities are incredibly exciting.

The ultimate reward is knowing that my day-to-day role can positively impact others.

Q: Why do you believe that partnerships are essential to generating positive outcomes?

A: With partnerships, it’s essential to go above and beyond the traditional approach in order to ensure that both sides will support each other’s business growth and needs.

For example, we recently partnered with Whitmire Medical, one of our valued distributors, to help onboard a client’s numerous clinics to our CardioChek® Plus for point-of-care cholesterol testing.

Whitmire was able to provide personalized logistic and implementation support, training, and troubleshooting assistance by educated point-of-care specialists. This extra layer of support ensured a successful experience.

Q: What do you like most about working with our corporate accounts?

A: Their goals and objectives always require an extremely high level of strategy and collaboration that will stretch the limits of all team members. Can-do attitudes, risk taking, teamwork, and innovation are a just a few of the traits that describe the companies and individuals that I work alongside. Their energy and passion for improving health outcomes is contagious.

Q: What else would you like to emphasize in regard to the healthcare industry and the accounts that you manage?

A: PTS Diagnostics understands the complexities of developing and implementing a chronic disease management program. Our experience with point-of-care technology and chronic disease management enables us to take key learnings from multiple clients and build a plan that is achievable.

Overall, all manufacturers and distributors are not created equal, so developing customized implementation plans are a must. Moreover, partnerships and business development must be continuous; as the industry changes, we must strategically adapt in order to achieve success.

We thank Bridget for lending us her time in order to highlight the importance of working with our retail partners in order to shed light on the positive changes being made as a result of our point-of-care solutions.

Readers with questions about any aspect of this blog are encouraged to connect with PTS Diagnostics.

Bridget Melland | Director of Corporate Accounts